BioCentury
ARTICLE | Company News

Blueprint Medicines management update

July 28, 2014 7:00 AM UTC

Blueprint Medicines, Cambridge, Mass. Business: Cancer Hired: Jeffrey Albers as CEO and a director, formerly U.S. president at Algeta ASA, which Bayer AG acquired; he succeeds co-founder and interim...